Proteome Sciences plc

As of December 31, 2025, Proteome Sciences plc carries a market capitalization of 737.96M, placing it among publicly traded companies globally. Its enterprise value stands at 2.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Proteome Sciences plc has 295.18M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Proteome Sciences plc maintains a current ratio of 0.13, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Proteome Sciences plc's stock has declined approximately 35.49% over the past 52 weeks. The 50-day moving average sits at 1.48, while the 200-day moving average is 1.73.

As of December 31, 2025, Proteome Sciences plc holds 78.10M in cash and equivalents against 1.58B in total debt, resulting in a net debt position of 1.37B. Total book value stands at -953.10M, with working capital of -1.45B providing operational flexibility.

Proteome Sciences plc's most recent stock split took place on June 14, 2010 with a 455:459 split ratio.